Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modigraf in Paediatric Allograft Recipients
NCT01371331Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2011
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 4, open-label, single-arm trial of Envarsus XR in kidney transplantation, heart transplantation and liver transplantation, sponsored by Astellas Pharma. Primary endpoints: Area under the plasma concentration-time curve for a dosing interval at Day 7, Maximum concentration at Day 7 and 2 more. Started Jun 2011; status: completed.
02
Drugs
Envarsus XR
03
Conditions
kidney transplantationheart transplantationliver transplantation
Beyond the preview
Go deeper on NCT01371331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01371331.